The Digital Health and Discovery Platform (DHDP) seeks to improve health outcomes for Canadians by accelerating precision medicine for cancer and neurological diseases such as Alzheimer’s. To attain this goal, the DHDP funds groundbreaking projects that:
All projects funded by the DHDP undergo a stringent peer-review process. This promotes scientific excellence and ensures funds go to top research projects across Canada. Proposals will also be evaluated by their engagement in the use of AI methods.
The purpose of this opportunity is to support the development of research programs through their use of the Platform. While the fund prioritizes oncology and neurology research programs, the DHDP is a disease agnostic initiative. Applications focused on other areas of health and AI research where similar data may be available (eg. diabetes, cardiology) will also be considered. By identifying and selecting research initiatives for their compelling science, projects will advance the design and use of the Platform to support meaningful and impactful projects. In parallel, the intention is to stimulate collaboration among small- and medium- sized enterprises (SMEs), while adopting a view toward the commercialization potential of research discoveries.
